SEC Filings - Supernus Pharmaceuticals

Filing date	Description	Form	Filing Group	View
February 28, 2020	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	View HTML 0001356576-20-000010.pdf 0001356576-20-000010.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
March 8, 2021	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	View HTML 0001356576-21-000028.pdf 0001356576-21-000028.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
April 13, 2022	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	View HTML 0001356576-22-000025.pdf 0001356576-22-000025.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
March 9, 2023	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	View HTML 0001356576-23-000016.pdf 0001356576-23-000016.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
February 27, 2024	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	View HTML 0001356576-24-000013.pdf 0001356576-24-000013.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
February 26, 2019	Annual filing director officer or owner of more than ten percent.	5	3,4,5	View HTML 0001104659-19-010791.pdf 0001104659-19-010791.xls
February 8, 2023	Annual filing director officer or owner of more than ten percent.	5	3,4,5	View HTML 0001104659-23-014592.pdf 0001104659-23-014592.xls
April 4, 2013	An annual report to security holders	ARS	Annual Filings	View HTML
April 11, 2014	An annual report to security holders	ARS	Annual Filings	View HTML
April 8, 2015	An annual report to security holders	ARS	Annual Filings	View HTML

Data provided by Kaleidoscope.